Thu, January 16, 2025
Wed, January 15, 2025
Tue, January 14, 2025
Mon, January 13, 2025
Sun, January 12, 2025
Sat, January 11, 2025
Fri, January 10, 2025
Thu, January 9, 2025
[ Thu, Jan 09th ] - Kiplinger
The Best Bank ETFs to Buy
Wed, January 8, 2025
Tue, January 7, 2025
Mon, January 6, 2025
Sun, January 5, 2025
Sat, January 4, 2025
Fri, January 3, 2025
[ Fri, Jan 03rd ] - MSN
3 Vanguard ETFs to Buy in 2025

Why are Mesoblast shares in a trading halt?


//stocks-investing.news-articles.net/content/202 .. /why-are-mesoblast-shares-in-a-trading-halt.html
Published in Stocks and Investing on by MSN   Print publication without navigation

The biotech company requested a trading halt before the market open on Friday. Here's why. The post Why are Mesoblast shares in a trading halt? appeared first on The Motley Fool Australia.

Mesoblast Limited, an Australian biotech company, has placed its shares in a trading halt pending an announcement regarding the potential approval of its cell therapy, remestemcel-L, by the U.S. Food and Drug Administration (FDA). This therapy is aimed at treating children with steroid-refractory acute graft versus host disease (SR-aGVHD), a severe condition that can occur after a bone marrow transplant. The FDA's decision, expected by August 2, 2023, could significantly impact Mesoblast's future, as the company has been working on this treatment for over a decade. The trading halt was initiated to manage market speculation and ensure an orderly market while awaiting the FDA's decision.

Read the Full MSN Article at:
[ https://www.msn.com/en-au/money/general/why-are-mesoblast-shares-in-a-trading-halt/ar-BB1rbOzS ]

Publication Contributing Sources